Clinical Trials in Lyon, Bron
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Multiple SclerosisRelapsing Remitting Multiple Sclerosis
Rennes University Hospital386 enrolled23 locationsNCT05758831
Recruiting
European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study
CIED Related Infection
University of Kiel2,300 enrolled8 locationsNCT04735666